|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000145819 |
Summary for ARHGAP26 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000145819 | Gene symbol | ARHGAP26 |
| Gene name | Rho GTPase activating protein 26 | |
| HGNC | 17073 | |
| Entrez ID | 23092 | |
| Gene type | protein_coding | |
| Synonyms | ARHGAP26|GRAF|KIAA0621|OPHN1L|OPHN1L1 | |
| UniProtAcc | Q9UNA1 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for ARHGAP26 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| ARHGAP26 | 7.85e+02 | -1.13e+00 | 2.16e-01 | -5.23e+00 | 1.68e-07 | 7.14e-07 | KICH |
| ARHGAP26 | 1.53e+03 | -1.07e+00 | 9.97e-02 | -1.07e+01 | 6.17e-27 | 2.78e-26 | BRCA |
Top |
Sex-biased somatic mutation for ARHGAP26 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for ARHGAP26 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Top |
Exon skipping events with PSI in TCGA for ARHGAP26 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Landscape of exon skipping events across multiple cancer types. |
 |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for ARHGAP26 |
| ∗Please access CAeditome for RNA editing annotation. |
| Landscape of RNA editing events across multiple cancer types. |
 |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| LUSC | ARHGAP26-011 | chr5_143225451_+ | 2.41e-01 | 1.83e-01 | 2.07e+00 | 3.84e-02 | 4.91e-02 | 5.76e-02 |
| SKCM | ARHGAP26-011 | chr5_143226413_+ | 5.99e-01 | 4.68e-01 | 2.10e+00 | 3.61e-02 | 4.90e-02 | 1.31e-01 |
| COAD | ARHGAP26-011 | chr5_143225451_+ | 1.95e-01 | 2.29e-01 | -2.21e+00 | 2.71e-02 | 3.85e-02 | -3.39e-02 |
| STAD | ARHGAP26-007 | chr5_143035816_+ | 2.42e-01 | 1.25e-01 | 2.01e+00 | 4.46e-02 | 4.96e-02 | 1.17e-01 |
| STAD | ARHGAP26-011 | chr5_143211781_+ | 5.27e-01 | 3.84e-01 | 2.51e+00 | 1.21e-02 | 4.96e-02 | 1.43e-01 |
| STAD | ARHGAP26-011 | chr5_143226322_+ | 4.07e-01 | 3.78e-01 | 2.68e+00 | 7.34e-03 | 4.96e-02 | 2.98e-02 |
| STAD | ARHGAP26-011 | chr5_143226413_+ | 6.70e-01 | 7.05e-01 | -2.63e+00 | 8.48e-03 | 4.96e-02 | -3.41e-02 |
| KIRP | ARHGAP26-011 | chr5_143225451_+ | 2.02e-01 | 1.31e-01 | 2.31e+00 | 2.09e-02 | 4.53e-02 | 7.12e-02 |
| KIRP | ARHGAP26-011 | chr5_143226322_+ | 3.50e-01 | 2.76e-01 | 2.81e+00 | 4.98e-03 | 3.52e-02 | 7.48e-02 |
| PAAD | ARHGAP26-011 | chr5_143226322_+ | 4.79e-01 | 3.51e-01 | 2.45e+00 | 1.43e-02 | 4.66e-02 | 1.27e-01 |
| READ | ARHGAP26-011 | chr5_143225353_+ | 5.11e-01 | 3.47e-01 | 3.06e+00 | 2.25e-03 | 4.67e-02 | 1.64e-01 |
| LAML | ARHGAP26-011 | chr5_143211781_+ | 3.46e-01 | 2.45e-01 | 2.03e+00 | 4.27e-02 | 4.95e-02 | 1.01e-01 |
| LAML | ARHGAP26-011 | chr5_143226436_+ | 2.41e-01 | 4.35e-01 | -2.72e+00 | 6.49e-03 | 4.94e-02 | -1.94e-01 |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| HNSC | ARHGAP26-011 | chr5_143225353_+ | 5.49e-01 | 4.11e-01 | 2.30e+00 | 2.15e-02 | 2.60e-02 | 1.37e-01 |
| COAD | ARHGAP26-011 | chr5_143225441_+ | 3.61e-01 | 2.40e-01 | 3.22e+00 | 1.26e-03 | 4.68e-03 | 1.21e-01 |
| COAD | ARHGAP26-011 | chr5_143226413_+ | 5.03e-01 | 3.89e-01 | 2.03e+00 | 4.26e-02 | 4.47e-02 | 1.15e-01 |
| STAD | ARHGAP26-011 | chr5_143226322_+ | 4.07e-01 | 3.19e-01 | 2.03e+00 | 4.28e-02 | 4.67e-02 | 8.88e-02 |
| KIRP | ARHGAP26-011 | chr5_143225441_+ | 3.26e-01 | 4.50e-01 | -2.58e+00 | 9.81e-03 | 2.24e-02 | -1.24e-01 |
| ESCA | ARHGAP26-011 | chr5_143225281_+ | 5.09e-01 | 3.68e-01 | 2.36e+00 | 1.84e-02 | 2.91e-02 | 1.41e-01 |
| ESCA | ARHGAP26-011 | chr5_143226406_+ | 5.90e-01 | 4.26e-01 | 2.75e+00 | 5.94e-03 | 1.62e-02 | 1.64e-01 |
| ESCA | ARHGAP26-011 | chr5_143226413_+ | 6.52e-01 | 4.97e-01 | 2.83e+00 | 4.61e-03 | 1.47e-02 | 1.55e-01 |
| ESCA | ARHGAP26-011 | chr5_143226436_+ | 4.05e-01 | 2.58e-01 | 2.67e+00 | 7.61e-03 | 1.79e-02 | 1.48e-01 |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| BRCA | ARHGAP26-011 | chr5_143225441_+ | 4.70e-01 | 4.06e-01 | 3.55e+00 | 3.91e-04 | 8.47e-04 | 6.39e-02 |
| BRCA | ARHGAP26-011 | chr5_143225871_+ | 2.32e-01 | 1.50e-01 | 3.73e+00 | 1.93e-04 | 4.52e-04 | 8.16e-02 |
| BRCA | ARHGAP26-011 | chr5_143226315_+ | 3.56e-01 | 2.50e-01 | 2.78e+00 | 5.52e-03 | 8.49e-03 | 1.06e-01 |
| BRCA | ARHGAP26-011 | chr5_143226322_+ | 4.68e-01 | 3.94e-01 | 2.12e+00 | 3.37e-02 | 3.69e-02 | 7.37e-02 |
| BRCA | ARHGAP26-011 | chr5_143226324_+ | 8.15e-01 | 6.29e-01 | 4.01e+00 | 6.14e-05 | 1.61e-04 | 1.86e-01 |
| BRCA | ARHGAP26-011 | chr5_143226406_+ | 5.28e-01 | 4.04e-01 | 2.05e+00 | 4.00e-02 | 4.21e-02 | 1.25e-01 |
| BRCA | ARHGAP26-011 | chr5_143226413_+ | 5.92e-01 | 4.71e-01 | 2.85e+00 | 4.33e-03 | 6.91e-03 | 1.21e-01 |
| BRCA | ARHGAP26-011 | chr5_143226431_+ | 2.53e-01 | 1.88e-01 | 2.19e+00 | 2.88e-02 | 3.26e-02 | 6.44e-02 |
| BRCA | ARHGAP26-011 | chr5_143226436_+ | 4.30e-01 | 3.34e-01 | 3.69e+00 | 2.23e-04 | 5.11e-04 | 9.54e-02 |
| STAD | ARHGAP26-011 | chr5_143226431_+ | 2.08e-01 | 1.21e-01 | 2.92e+00 | 3.51e-03 | 2.47e-02 | 8.71e-02 |
| STAD | ARHGAP26-011 | chr5_143226436_+ | 4.05e-01 | 3.21e-01 | 2.06e+00 | 3.93e-02 | 4.55e-02 | 8.40e-02 |
| KIRP | ARHGAP26-011 | chr5_143226436_+ | 2.93e-01 | 4.16e-01 | -2.04e+00 | 4.16e-02 | 4.61e-02 | -1.22e-01 |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for ARHGAP26 |
| TFs related to ARHGAP26. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| SKCM | ATOH7 | ARHGAP26 | 4.88e+00 | 9.80e-01 | 3.90e+00 | 1.22e-02 | Male-biased |
| SKCM | BHLHE22 | ARHGAP26 | 4.80e+00 | 9.86e-01 | 3.55e+00 | 5.53e-03 | Male-biased |
| SKCM | HMBOX1 | ARHGAP26 | 5.25e+00 | 9.85e-01 | 4.24e+00 | 1.13e-02 | Male-biased |
| SKCM | HOXA9 | ARHGAP26 | 4.26e+00 | 9.82e-01 | 2.51e+00 | 1.11e-03 | Male-biased |
| SKCM | IRX3 | ARHGAP26 | 4.52e+00 | 9.81e-01 | 3.33e+00 | 6.51e-03 | Male-biased |
| SKCM | OLIG1 | ARHGAP26 | 4.87e+00 | 9.84e-01 | 3.77e+00 | 8.64e-03 | Male-biased |
| SKCM | OLIG3 | ARHGAP26 | 4.86e+00 | 9.84e-01 | 3.75e+00 | 8.38e-03 | Male-biased |
| SKCM | SOX2 | ARHGAP26 | 4.23e+00 | 9.82e-01 | 2.39e+00 | 8.17e-04 | Male-biased |
| ARHGAP26 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for ARHGAP26 |
| RBPs related to ES in ARHGAP26. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| STAD | SAMD4A | exon_skip_438367 | 6.39e+00 | 7.57e-04 | 7.03e+00 | 9.86e-01 | Female-biased |
| COAD | SAMD4A | exon_skip_438367 | 6.73e+00 | 9.82e-01 | 6.21e+00 | 1.76e-03 | Male-biased |
| ESCA | HNRNPA2B1 | exon_skip_438368 | 1.16e+01 | 5.04e-03 | 1.22e+01 | 9.95e-01 | Female-biased |
| READ | HNRNPA2B1 | exon_skip_438368 | 1.23e+01 | 9.98e-01 | 1.18e+01 | 1.81e-03 | Male-biased |
| READ | SAMD4A | exon_skip_438367 | 6.14e+00 | 6.46e-04 | 6.73e+00 | 9.84e-01 | Female-biased |
| ARHGAP26 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
| ENSG00000145819 | AC019205.1,hsa-mir-143,ARHGAP26 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000145819 | PCAT19,hsa-mir-143,ARHGAP26 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000145819 | MIR223HG,hsa-mir-143,ARHGAP26 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000145819 | LOXL1-AS1,hsa-mir-143,ARHGAP26 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000145819 | FAM66C,hsa-mir-143,ARHGAP26 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000145819 | AC011447.3,hsa-mir-143,ARHGAP26 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000145819 | AP002957.1,hsa-mir-143,ARHGAP26 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000145819 | AF001548.1,hsa-mir-143,ARHGAP26 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000145819 | CRYZL2P-SEC16B,hsa-mir-143,ARHGAP26 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000145819 | AC073508.3,hsa-mir-143,ARHGAP26 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000145819 | PCAT19,hsa-mir-216a,ARHGAP26 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000145819 | EPHA1-AS1,hsa-mir-216a,ARHGAP26 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000145819 | AL445183.2,hsa-mir-216a,ARHGAP26 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000145819 | AL358472.2,hsa-mir-216a,ARHGAP26 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000145819 | CYP1B1-AS1,hsa-mir-216a,ARHGAP26 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000145819 | FAM66C,hsa-mir-760,ARHGAP26 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000145819 | CYP1B1-AS1,hsa-mir-760,ARHGAP26 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000145819 | AC019205.1,hsa-mir-760,ARHGAP26 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000145819 | AL117336.2,hsa-mir-760,ARHGAP26 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000145819 | LOXL1-AS1,hsa-mir-760,ARHGAP26 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000145819 | RRN3P2,hsa-mir-760,ARHGAP26 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000145819 | ARHGAP27P1-BPTFP1-KPNA2P3,hsa-mir-760,ARHGAP26 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000145819 | AC016026.1,hsa-mir-760,ARHGAP26 | Female-specific ceRNA | TCGA-KICH |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs2603008 | chr5:135316704:A:T | - | 0.152131122400111 | 0.00641377631430481 | LUSC | Female-baised eQTL |
| rs77181727 | chr5:147670707:G:A | - | 0.107229868328126 | 0.00211248773442916 | LUAD | Female-baised eQTL |
| rs77008573 | chr5:147650031:G:A | - | 0.108344348295886 | 0.00281820040661952 | LUAD | Female-baised eQTL |
| rs77866435 | chr5:147653762:G:A | - | 0.108344348295886 | 0.00281820040661952 | LUAD | Female-baised eQTL |
| rs139928138 | chr5:147657237:G:A | - | 0.108344348295886 | 0.00281820040661952 | LUAD | Female-baised eQTL |
| rs76538910 | chr5:147658498:C:T | - | 0.108344348295886 | 0.00281820040661952 | LUAD | Female-baised eQTL |
| rs55698590 | chr5:147669179:A:G | - | 0.108344348295886 | 0.00281820040661952 | LUAD | Female-baised eQTL |
| rs75826555 | chr5:147668306:C:T | - | 0.103133129153881 | 0.00527629006042102 | LUAD | Female-baised eQTL |
| rs78414050 | chr5:147670823:A:G | - | 0.104993210624464 | 0.00530543555093895 | LUAD | Female-baised eQTL |
| rs80071099 | chr5:147634540:G:A | - | 0.0999373919571382 | 0.0120274340155849 | LUAD | Female-baised eQTL |
| rs74944118 | chr5:147675873:C:T | - | 0.0930409151614764 | 0.0352827385374252 | LUAD | Female-baised eQTL |
| rs6887975 | chr5:145958076:A:G | - | 0.142293327258899 | 0.00136779202893179 | COAD | Female-baised eQTL |
| rs6897959 | chr5:145958923:T:C | - | 0.142293327258899 | 0.00136779202893179 | COAD | Female-baised eQTL |
| rs1123825 | chr5:144437293:A:G | - | 0.144211174206435 | 0.00338191645727053 | COAD | Female-baised eQTL |
| rs2127569 | chr5:146963364:C:G | - | -0.0911918137744907 | 0.00579043821454106 | COAD | Female-baised eQTL |
| rs2400232 | chr5:146982533:A:C | - | -0.0791071278091288 | 0.0061008478531063 | COAD | Female-baised eQTL |
| rs2033449 | chr5:148223782:A:G | - | 0.133839018080704 | 0.00722867924821538 | COAD | Female-baised eQTL |
| rs4705453 | chr5:146966921:T:C | - | -0.0897964821375149 | 0.00785078127739018 | COAD | Female-baised eQTL |
| rs4705124 | chr5:146965701:A:T | - | -0.0905822295712369 | 0.00828631287783685 | COAD | Female-baised eQTL |
| rs4705452 | chr5:146966147:T:C | - | -0.0884882525918151 | 0.00914923129307371 | COAD | Female-baised eQTL |
| rs6898335 | chr5:146966637:C:T | - | -0.0884882525918151 | 0.00914923129307371 | COAD | Female-baised eQTL |
| rs11953078 | chr5:146967889:T:C | - | -0.0884882525918151 | 0.00914923129307371 | COAD | Female-baised eQTL |
| rs2603008 | chr5:135316704:A:T | - | 0.130984767790459 | 0.0115105050990768 | COAD | Female-baised eQTL |
| rs6876098 | chr5:147010689:G:A | - | 0.0813221903600695 | 0.0128791816879877 | COAD | Female-baised eQTL |
| rs4552686 | chr5:147011202:A:G | - | 0.0813221903600695 | 0.0128791816879877 | COAD | Female-baised eQTL |
| rs4489112 | chr5:147011308:A:G | - | 0.0813221903600695 | 0.0128791816879877 | COAD | Female-baised eQTL |
| rs4273646 | chr5:147012777:G:T | - | 0.0813221903600695 | 0.0128791816879877 | COAD | Female-baised eQTL |
| rs10073446 | chr5:147013031:C:T | - | 0.0813221903600695 | 0.0128791816879877 | COAD | Female-baised eQTL |
| rs2199840 | chr5:147011626:T:C | - | 0.0803559199920341 | 0.0129629739975236 | COAD | Female-baised eQTL |
| rs3088225 | chr5:133051568:A:G | - | 0.0771070205246131 | 0.0133743731198905 | COAD | Female-baised eQTL |
| rs2400235 | chr5:146972095:C:A | - | -0.0790360731453677 | 0.0136748007484617 | COAD | Female-baised eQTL |
| rs9325028 | chr5:146994072:C:T | - | 0.0803294166711805 | 0.0146568200291547 | COAD | Female-baised eQTL |
| rs10875618 | chr5:146996224:T:C | - | 0.080419563241243 | 0.0147499105944085 | COAD | Female-baised eQTL |
| rs10067207 | chr5:147001369:A:G | - | 0.080419563241243 | 0.0147499105944085 | COAD | Female-baised eQTL |
| rs13362410 | chr5:147007157:A:G | - | 0.080419563241243 | 0.0147499105944085 | COAD | Female-baised eQTL |
| rs10476881 | chr5:147007902:G:A | - | 0.080419563241243 | 0.0147499105944085 | COAD | Female-baised eQTL |
| rs10477316 | chr5:147002528:A:G | - | 0.0794656445661168 | 0.014844584188377 | COAD | Female-baised eQTL |
| rs11167949 | chr5:146975473:G:A | - | -0.0767774764105516 | 0.0159376963102385 | COAD | Female-baised eQTL |
| rs13359973 | chr5:147011937:C:T | - | 0.0801541029530934 | 0.0163312186601671 | COAD | Female-baised eQTL |
| rs9325030 | chr5:147017059:A:T | - | 0.0776585414327168 | 0.0196728018807389 | COAD | Female-baised eQTL |
| rs11167921 | chr5:145961545:C:T | - | 0.0839722698778084 | 0.0289748535369024 | COAD | Female-baised eQTL |
| rs4912700 | chr5:145962529:T:C | - | 0.0839722698778084 | 0.0289748535369024 | COAD | Female-baised eQTL |
| rs4912701 | chr5:145962768:A:C | - | 0.0839722698778084 | 0.0289748535369024 | COAD | Female-baised eQTL |
| rs7725650 | chr5:145970170:A:C | - | 0.0839722698778084 | 0.0289748535369024 | COAD | Female-baised eQTL |
| rs1432774 | chr5:145972140:G:T | - | 0.0839722698778084 | 0.0289748535369024 | COAD | Female-baised eQTL |
| rs17803508 | chr5:151627176:G:A | - | 0.162209509284111 | 0.0312595174308437 | COAD | Female-baised eQTL |
| rs17741373 | chr5:151627331:T:C | - | 0.161577644947008 | 0.0325283699726827 | COAD | Female-baised eQTL |
| rs73275850 | chr5:151625735:G:A | - | 0.155887339675764 | 0.0382132665989509 | COAD | Female-baised eQTL |
| rs17741337 | chr5:151620596:C:T | - | 0.155531966760529 | 0.0389795430799296 | COAD | Female-baised eQTL |
| rs6579881 | chr5:151623885:C:T | - | 0.155252187560617 | 0.0398015378240255 | COAD | Female-baised eQTL |
| rs4367292 | chr5:133099880:C:T | - | 0.0694017072966195 | 0.0413748744908203 | COAD | Female-baised eQTL |
| rs114164650 | chr5:142575239:T:C | - | 0.106237129139423 | 0.0425338441618213 | COAD | Female-baised eQTL |
| rs73275351 | chr5:142575240:G:C | - | 0.106237129139423 | 0.0425338441618213 | COAD | Female-baised eQTL |
| rs115614870 | chr5:142575241:G:A | - | 0.106237129139423 | 0.0425338441618213 | COAD | Female-baised eQTL |
| rs62375248 | chr5:133107369:T:A | - | 0.0691321018646279 | 0.0447752168045364 | COAD | Female-baised eQTL |
| rs73276135 | chr5:150665460:G:A | - | 0.0904480545536995 | 0.0452336946790466 | COAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs7703395 | chr5:137596458:A:G | - | 0.112873255713954 | 0.0408113404332599 | SARC | Male-baised eQTL |
| rs6596398 | chr5:137596878:G:A | - | 0.112873255713954 | 0.0408113404332599 | SARC | Male-baised eQTL |
| rs7709784 | chr5:137597820:G:A | - | 0.112873255713954 | 0.0408113404332599 | SARC | Male-baised eQTL |
| rs6869801 | chr5:140280343:C:T | - | -0.0589162459512843 | 0.00913614971585834 | KIRC | Male-baised eQTL |
| rs6580498 | chr5:140284816:C:T | - | -0.0586121165856891 | 0.00985144750016501 | KIRC | Male-baised eQTL |
| rs6580453 | chr5:140224934:T:C | - | -0.05778632798194 | 0.013721411409054 | KIRC | Male-baised eQTL |
| rs369171 | chr5:140202142:G:T | - | 0.0578072681076594 | 0.013944197966305 | KIRC | Male-baised eQTL |
| rs1432874 | chr5:140231695:G:A | - | -0.056559527882213 | 0.0182480503829603 | KIRC | Male-baised eQTL |
| rs10875566 | chr5:151647402:A:G | - | 0.0478020847063151 | 0.0442120046705509 | KIRC | Male-baised eQTL |
| rs111440401 | chr5:143366458:C:T | - | 0.0424695239387023 | 0.0368679171556665 | BLCA | Male-baised eQTL |
| rs10052957 | chr5:143407136:G:A | - | 0.0414103594974307 | 0.0453738259344534 | BLCA | Male-baised eQTL |
| rs2963151 | chr5:143354586:T:C | - | 0.0583728150084265 | 0.0457411585086144 | BLCA | Male-baised eQTL |
| rs61072686 | chr5:133236379:C:T | - | 0.106921507279101 | 0.0161798371458454 | COAD | Male-baised eQTL |
| rs17107349 | chr5:147861541:C:G | - | 0.0665621456610288 | 0.0230359604860102 | COAD | Male-baised eQTL |
| rs7704793 | chr5:144705798:A:T | - | 0.0528973156627422 | 0.0257898679721498 | COAD | Male-baised eQTL |
| rs73799452 | chr5:151132885:C:T | - | 0.0888278534496349 | 0.0312926813243837 | COAD | Male-baised eQTL |
| rs1432646 | chr5:147237964:T:A | - | -0.0514149791322801 | 0.0376796558068938 | COAD | Male-baised eQTL |
| rs4705137 | chr5:147242676:C:T | - | -0.055035029514474 | 0.047934729211638 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
 | Gene ID: ENSG00000145819 |
| CpG Site: cg18844163 | |
| Position to Gene: gene | |
| Male Effect: -0.308353276561855 | |
| Female Effect: - | |
 | Gene ID: ENSG00000145819 |
| CpG Site: cg02291619 | |
| Position to Gene: gene | |
| Male Effect: -0.380139202899914 | |
| Female Effect: - | |
 | Gene ID: ENSG00000145819 |
| CpG Site: cg22188603 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.413089061743084 | |
 | Gene ID: ENSG00000145819 |
| CpG Site: cg11366683 | |
| Position to Gene: gene | |
| Male Effect: - | |
| Female Effect: -0.229378462751785 |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg18844163 | chr5:142982558 | gene | -0.308353276561855 | 1.34945822078644e-06 | -0.5467101282602114 | 5.7510393686402916e-09 | PAAD |
| cg02291619 | chr5:142824171 | gene | -0.380139202899914 | 8.16767863435776e-05 | -0.4800684548415026 | 5.670005045686243e-07 | PAAD |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg22188603 | chr5:142864204 | gene | -0.413089061743084 | 6.48417074555397e-05 | -0.3137056581529787 | 3.144792897726704e-07 | LUAD |
| cg11366683 | chr5:142810001 | gene | -0.229378462751785 | 7.03264750972725e-07 | -0.42982794033202365 | 1.918948677590667e-09 | SKCM |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of ARHGAP26 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
| ENSG00000145819 | ARHGAP26 | C0033975 | Psychotic Disorders | 1 | PSYGENET |
| ENSG00000145819 | ARHGAP26 | C0349639 | Juvenile Myelomonocytic Leukemia | 1 | CTD_human |
